Testing effectiveness (Phase 2)Ended earlyNCT00969722
What this trial is testing
MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients
Who this might be right for
Primary Refractory Neuroblastoma
United Therapeutics 1